- Home
- BDL vs RFL Comparison
BDL vs RFL Comparison
Compare BDL & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- RFL
- Stock Information
- Founded
- BDL 1959
- RFL 2017
- Country
- BDL United States
- RFL United States
- Employees
- BDL N/A
- RFL N/A
- Industry
- BDL Restaurants
- RFL Real Estate
- Sector
- BDL Consumer Discretionary
- RFL Finance
- Exchange
- BDL Nasdaq
- RFL Nasdaq
- Market Cap
- BDL 48.7M
- RFL 48.4M
- IPO Year
- BDL N/A
- RFL N/A
- Fundamental
- Price
- BDL $26.10
- RFL $2.26
- Analyst Decision
- BDL
- RFL
- Analyst Count
- BDL 0
- RFL 0
- Target Price
- BDL N/A
- RFL N/A
- AVG Volume (30 Days)
- BDL 1.4K
- RFL 57.4K
- Earning Date
- BDL 08-13-2024
- RFL 10-28-2024
- Dividend Yield
- BDL 1.89%
- RFL N/A
- EPS Growth
- BDL N/A
- RFL N/A
- EPS
- BDL 1.64
- RFL N/A
- Revenue
- BDL $185,457,000.00
- RFL $540,000.00
- Revenue This Year
- BDL N/A
- RFL N/A
- Revenue Next Year
- BDL N/A
- RFL N/A
- P/E Ratio
- BDL $16.12
- RFL N/A
- Revenue Growth
- BDL 8.71
- RFL 92.86
- 52 Week Low
- BDL $24.43
- RFL $1.29
- 52 Week High
- BDL $29.75
- RFL $2.29
- Technical
- Relative Strength Index (RSI)
- BDL 48.47
- RFL 84.25
- Support Level
- BDL $25.52
- RFL $2.00
- Resistance Level
- BDL $27.00
- RFL $1.94
- Average True Range (ATR)
- BDL 0.24
- RFL 0.10
- MACD
- BDL -0.13
- RFL 0.02
- Stochastic Oscillator
- BDL 26.81
- RFL 95.31
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service and Package stores consist of retail liquor sales and related items. The company generates maximum revenue from Restaurant segment.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.